TetraScience

TetraScience, founded in April 2015 and headquartered in Boston, MA, with remote work options, operates in the Healthcare and Healthcare IT industries. The company has a team of 100 employees and participated in Y Combinator’s S15 batch. TetraScience provides a suite of next-generation lab data management solutions designed to enable Scientific AI from the ground up. Their offerings prevent proprietary walled gardens and vendor lock-in with a vendor-agnostic data stack, ensuring data liquidity and AI collaboration among scientific customers and their partners.

TetraScience’s solutions include data replatforming, data engineering, data analytics, AI, GxP compliance, and Tetra Catalysts. They support various scientific outcomes such as asset utilization, biologics characterization, bioprocessing purification, chromatography, CxO collaboration, flow cytometry, formulation development, high-throughput screening, QC for biologics, and QC for small molecules. The company aims to shatter the century-old scientific data silo paradigm by building a revolutionary, future-proof scientific data and AI foundation.

The Tetra Data Platform offers easy access to centralized, harmonized, and actionable scientific data, providing the world’s first and only R&D Data Cloud for life sciences. TetraScience partners with leading biopharma organizations, including AstraZeneca, Amgen, Genentech, Novartis, Regeneron, and Merck, to transform life sciences R&D, accelerate discovery, and improve human life. Their customers achieve materially improved outcomes, including increased scientific, IT, and data science productivity, reduced research, development, and manufacturing costs, and lower risks across the scientific value chain.